Burikhanov, Ravshan
Sviripa, Vitaliy M
Hebbar, Nikhil
Zhang, Wen
Layton, W John
Hamza, Adel
Zhan, Chang-Guo
Watt, David S
Liu, Chunming
Rangnekar, Vivek M
Article History
Received: 20 March 2014
Accepted: 13 August 2014
First Online: 14 September 2014
Competing interests
: V.M.R., D.S.W. and C.L. hold 30% equity each in a limited liability corporation, Curonc LLC, founded for the purpose of advancing translational research involving arylquins, and the University of Kentucky has filed a preliminary patent application for these compounds in which these authors are co-inventors.